Ministry of Education Key Laboratory of Child Development and Disorders, Department of Growth, Development, and Mental Health of Children and Adolescence Center, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China; Chongqing Key Laboratory of Child Health and Nutrition, Chongqing, China.
Chongqing Key Laboratory of Child Health and Nutrition, Chongqing, China.
Front Endocrinol (Lausanne). 2022 Dec 19;13:1063989. doi: 10.3389/fendo.2022.1063989. eCollection 2022.
There are no prospective longitudinal studies on the association between well-controlled gestational diabetes mellitus (GDM) without pharmacologic therapy and the physical growth of offspring in infancy. We aimed to identify the trajectories in physical growth (from 0-12 months of age) in the offspring of mothers with well-controlled GDM without pharmacologic therapy in a prospective cohort in China.
This study included 236 offspring of mothers with GDM and 369 offspring of mothers without GDM. Mothers with GDM were not on pharmacologic therapy. The length and weight of infants were measured at 0, 1, 3, 6, and 12 months. Linear mixed-effect models and linear mixed-effect models were applied.
The fully adjusted model showed that the weight-for-age z-score (WAZ), length-for-age z-score (LAZ), and BMI-for-age z-score (BMIZ) were similar at birth for the GDM and control groups. However, subsequent increases in WAZ and BMIZ for the GDM group lagged the increases for the control group at the subsequent periods of observation, 0-1, 0-6, and 0-12 months.
Well-controlled GDM without pharmacologic therapy may normalize physical growth of offspring at birth and decelerate their weight gain in infancy. Whether glycemic control can mitigate the long-term effects of GDM on the growth trajectory in offspring remains unclear.
目前尚无前瞻性纵向研究探讨未经药物治疗的血糖控制良好的妊娠期糖尿病(GDM)与婴儿期后代身体生长之间的关系。我们旨在确定中国一项前瞻性队列中未经药物治疗的血糖控制良好的 GDM 母亲所生孩子在 0-12 个月时的身体生长轨迹(0-12 个月)。
本研究纳入了 236 名 GDM 母亲所生孩子和 369 名非 GDM 母亲所生孩子。GDM 母亲未接受药物治疗。婴儿的身长和体重在 0、1、3、6 和 12 个月时进行测量。采用线性混合效应模型和线性混合效应模型进行分析。
完全调整模型显示,GDM 组和对照组在出生时体重与年龄的 Z 评分(WAZ)、身长与年龄的 Z 评分(LAZ)和体重指数与年龄的 Z 评分(BMIZ)相似。然而,在随后的观察期 0-1、0-6 和 0-12 个月期间,GDM 组的 WAZ 和 BMIZ 后续增加速度滞后于对照组。
未经药物治疗的血糖控制良好的 GDM 可能会使后代在出生时的身体生长正常化,并减缓其在婴儿期的体重增加。血糖控制是否能减轻 GDM 对后代生长轨迹的长期影响尚不清楚。